Literature DB >> 2070708

Hepatocyte proliferation in stepwise development of experimental liver cell cancer.

E Farber1.   

Abstract

Cell proliferation is the most central and key phenotypic property of cancer including hepatocellular carcinoma. Hepatocyte proliferation is central not only at the late steps in carcinogenesis, the cancer, but at the earliest known step, initiation. Compensatory or regenerative hepatocyte proliferation is essential to initiation with chemical carcinogens but primary hyperplasia is ineffective. During promotion, hepatocyte proliferation is the major change seen as clonal proliferation to generate nodules occurs. During progression, autonomous hepatocyte proliferation balanced by cell loss makes its appearance. This continues in a balanced fashion with only a slight excess of proliferation over loss until the earlier steps in malignancy at which time the balance is disrupted.

Entities:  

Mesh:

Year:  1991        PMID: 2070708     DOI: 10.1007/BF01297150

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  The carcinogenic effect of aramite in rats. A study of hepatic nodules.

Authors:  H POPPER; S S STERNBERG; B L OSER; M OSER
Journal:  Cancer       Date:  1960 Sep-Oct       Impact factor: 6.860

2.  Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene.

Authors:  E FARBER
Journal:  Cancer Res       Date:  1956-02       Impact factor: 12.701

3.  Induction of liver growth by xenobiotic compounds and other stimuli.

Authors:  R Schulte-Hermann
Journal:  CRC Crit Rev Toxicol       Date:  1974-09

Review 4.  The first relevant cell stage in rat liver carcinogenesis. A quantitative approach.

Authors:  P Emmelot; E Scherer
Journal:  Biochim Biophys Acta       Date:  1980-05-06

Review 5.  Some emerging general principles in the pathogenesis of hepatocellular carcinoma.

Authors:  E Farber
Journal:  Cancer Surv       Date:  1986

6.  Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens.

Authors:  G M Ledda-Columbano; A Columbano; M Curto; M G Ennas; P Coni; D S Sarma; P Pani
Journal:  Carcinogenesis       Date:  1989-05       Impact factor: 4.944

7.  Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. II. Induction of growth.

Authors:  R Schulte-Hermann; V Hoffman; W Parzefall; M Kallenbach; A Gerhardt; J Schuppler
Journal:  Chem Biol Interact       Date:  1980-09       Impact factor: 5.192

8.  Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice.

Authors:  F V Chisari; P Filippi; J Buras; A McLachlan; H Popper; C A Pinkert; R D Palmiter; R L Brinster
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

9.  Cell cycle kinetics of rat hepatocytes in early putative preneoplastic lesions in hepatocarcinogenesis.

Authors:  J Rotstein; P D Macdonald; H M Rabes; E Farber
Journal:  Cancer Res       Date:  1984-07       Impact factor: 12.701

10.  Failure of mitogen-induced cell proliferation to achieve initiation of rat liver carcinogenesis.

Authors:  A Columbano; G M Ledda-Columbano; P Coni; P Pani
Journal:  Carcinogenesis       Date:  1987-02       Impact factor: 4.944

View more
  9 in total

1.  Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.

Authors:  H-C Chi; S-L Chen; S-L Lin; C-Y Tsai; W-Y Chuang; Y-H Lin; Y-H Huang; M-M Tsai; C-T Yeh; K-H Lin
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

2.  Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications.

Authors:  H Kirimlioglu; I Dvorchick; K Ruppert; S Finkelstein; J W Marsh; S Iwatsuki; A Bonham; B Carr; M Nalesnik; G Michalopoulos; T Starzl; J Fung; A Demetris
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

Review 3.  The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis.

Authors:  Xiaomin Lou; Ju Zhang; Siqi Liu; Ningzhi Xu; D Joshua Liao
Journal:  Cell Cycle       Date:  2014-05-05       Impact factor: 4.534

4.  Gastric mucosa lesions induced by duodenogastric reflux increase penetration of N-[3H]-methyl-N-nitro-N-nitrosoguanidine into corpus mucosa of rats.

Authors:  Kjell K Ovrebø; Knut Svanes; Steinar Aase; Ketil Grong; Steinar Kvinnsland; Halfdan Sørbye
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

Review 5.  Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.

Authors:  Xixi Dou; Pingzhen Tong; Hai Huang; Lucas Zellmer; Yan He; Qingwen Jia; Daizhou Zhang; Jiang Peng; Chenguang Wang; Ningzhi Xu; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

Review 6.  Cell proliferation and apoptosis in normal liver and preneoplastic foci.

Authors:  R Schulte-Hermann; W Bursch; B Kraupp-Grasl; F Oberhammer; A Wagner; R Jirtle
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

Review 7.  Molecular functions of thyroid hormones and their clinical significance in liver-related diseases.

Authors:  Hsiang Cheng Chi; Cheng-Yi Chen; Ming-Ming Tsai; Chung-Ying Tsai; Kwang-Huei Lin
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

8.  Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway.

Authors:  Hsiang-Cheng Chi; Shen-Liang Chen; Yi-Hung Cheng; Tzu-Kang Lin; Chung-Ying Tsai; Ming-Ming Tsai; Yang-Hsiang Lin; Ya-Hui Huang; Kwang-Huei Lin
Journal:  Cell Death Dis       Date:  2016-08-04       Impact factor: 8.469

9.  Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.

Authors:  Na Shang; Thomas Bank; Xianzhong Ding; Peter Breslin; Jun Li; Baomin Shi; Wei Qiu
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.